JP2022046669A5 - - Google Patents

Download PDF

Info

Publication number
JP2022046669A5
JP2022046669A5 JP2021211779A JP2021211779A JP2022046669A5 JP 2022046669 A5 JP2022046669 A5 JP 2022046669A5 JP 2021211779 A JP2021211779 A JP 2021211779A JP 2021211779 A JP2021211779 A JP 2021211779A JP 2022046669 A5 JP2022046669 A5 JP 2022046669A5
Authority
JP
Japan
Prior art keywords
sample
assay
subject
recovery
hours
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021211779A
Other languages
English (en)
Japanese (ja)
Other versions
JP7217796B2 (ja
JP2022046669A (ja
Filing date
Publication date
Priority claimed from JP2020185705A external-priority patent/JP7002623B2/ja
Application filed filed Critical
Publication of JP2022046669A publication Critical patent/JP2022046669A/ja
Publication of JP2022046669A5 publication Critical patent/JP2022046669A5/ja
Priority to JP2023008480A priority Critical patent/JP2023052587A/ja
Application granted granted Critical
Publication of JP7217796B2 publication Critical patent/JP7217796B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021211779A 2014-10-20 2021-12-27 腎障害および腎不全の診断および予後のための方法および組成物 Active JP7217796B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023008480A JP2023052587A (ja) 2014-10-20 2023-01-24 腎障害および腎不全の診断および予後のための方法および組成物

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201462066316P 2014-10-20 2014-10-20
US201462066313P 2014-10-20 2014-10-20
US201462066310P 2014-10-20 2014-10-20
US62/066,313 2014-10-20
US62/066,316 2014-10-20
US62/066,310 2014-10-20
JP2020185705A JP7002623B2 (ja) 2014-10-20 2020-11-06 腎障害および腎不全の診断および予後のための方法および組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020185705A Division JP7002623B2 (ja) 2014-10-20 2020-11-06 腎障害および腎不全の診断および予後のための方法および組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023008480A Division JP2023052587A (ja) 2014-10-20 2023-01-24 腎障害および腎不全の診断および予後のための方法および組成物

Publications (3)

Publication Number Publication Date
JP2022046669A JP2022046669A (ja) 2022-03-23
JP2022046669A5 true JP2022046669A5 (https=) 2022-07-08
JP7217796B2 JP7217796B2 (ja) 2023-02-03

Family

ID=55761743

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2017521231A Active JP6792553B2 (ja) 2014-10-20 2015-10-20 腎障害および腎不全の診断および予後のための方法および組成物
JP2020185705A Active JP7002623B2 (ja) 2014-10-20 2020-11-06 腎障害および腎不全の診断および予後のための方法および組成物
JP2021211779A Active JP7217796B2 (ja) 2014-10-20 2021-12-27 腎障害および腎不全の診断および予後のための方法および組成物
JP2023008480A Pending JP2023052587A (ja) 2014-10-20 2023-01-24 腎障害および腎不全の診断および予後のための方法および組成物

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2017521231A Active JP6792553B2 (ja) 2014-10-20 2015-10-20 腎障害および腎不全の診断および予後のための方法および組成物
JP2020185705A Active JP7002623B2 (ja) 2014-10-20 2020-11-06 腎障害および腎不全の診断および予後のための方法および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023008480A Pending JP2023052587A (ja) 2014-10-20 2023-01-24 腎障害および腎不全の診断および予後のための方法および組成物

Country Status (13)

Country Link
US (2) US11333671B2 (https=)
EP (2) EP3968022A1 (https=)
JP (4) JP6792553B2 (https=)
KR (1) KR102431003B1 (https=)
CN (2) CN107003301B (https=)
AU (2) AU2015336069B2 (https=)
BR (1) BR112017008218A2 (https=)
CA (1) CA2965153C (https=)
EA (1) EA201790696A1 (https=)
ES (1) ES2907551T3 (https=)
MX (1) MX388231B (https=)
PT (1) PT3210018T (https=)
WO (1) WO2016064877A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107003301B (zh) 2014-10-20 2019-11-01 阿斯图特医药公司 用于诊断和预后肾损伤和肾衰竭的方法和组合物
JP2020504157A (ja) * 2017-01-12 2020-02-06 アスチュート メディカル,インコーポレイテッド C−cモチーフケモカインリガンド14の測定に基づく腎損傷および腎不全の評価および処置のための方法および組成物
US11346846B2 (en) 2017-02-06 2022-05-31 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US11891439B2 (en) 2017-12-28 2024-02-06 Astute Medical, Inc. Antibodies and assays for CCL14
US12114978B2 (en) 2018-04-02 2024-10-15 Potrero Medical, Inc. Systems, devices and methods for draining and analyzing bodily fluids and assessing health
CN119454032A (zh) * 2018-04-02 2025-02-18 波特雷罗医疗公司 用于排出和分析体液并评估健康的系统、设备和方法
CN114207436A (zh) * 2019-05-24 2022-03-18 机敏医药股份有限公司 基于c-c基序趋化因子配体14测量而评估和治疗肾损伤的方法
US20230290457A1 (en) * 2020-03-23 2023-09-14 Biocogniv Inc. Artificial intelligence medical device
GB2596142B (en) * 2020-06-19 2023-11-29 Secr Defence Methods and associated uses, kits and systems for assessing sepsis
AU2021381364A1 (en) * 2020-11-18 2023-06-22 Astute Medical, Inc. Methods and compositions for treatment of renal injury and renal failure
WO2023168299A1 (en) * 2022-03-03 2023-09-07 Astute Medical, Inc. Methods and compositions for assessing and treating persistent acute kidney injury based on c-c motif chemokine ligand 14 measurement

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5028535A (en) 1989-01-10 1991-07-02 Biosite Diagnostics, Inc. Threshold ligand-receptor assay
US5939272A (en) 1989-01-10 1999-08-17 Biosite Diagnostics Incorporated Non-competitive threshold ligand-receptor assays
US5922615A (en) 1990-03-12 1999-07-13 Biosite Diagnostics Incorporated Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network
CA2072758A1 (en) 1990-09-14 1992-03-15 Kenneth Francis Buechler Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays
US5955377A (en) 1991-02-11 1999-09-21 Biostar, Inc. Methods and kits for the amplification of thin film based assays
CA2107894C (en) 1991-04-10 2003-10-14 Kenneth F. Buechler Crosstalk inhibitors and their uses
EP0579767B1 (en) 1991-04-11 2000-08-23 Biosite Diagnostics Inc. Novel conjugates and assays for simultaneous detection of multiple ligands
US6019944A (en) 1992-05-21 2000-02-01 Biosite Diagnostics, Inc. Diagnostic devices and apparatus for the controlled movement of reagents without membranes
US6143576A (en) 1992-05-21 2000-11-07 Biosite Diagnostics, Inc. Non-porous diagnostic devices for the controlled movement of reagents
US5494829A (en) 1992-07-31 1996-02-27 Biostar, Inc. Devices and methods for detection of an analyte based upon light interference
US5824799A (en) 1993-09-24 1998-10-20 Biosite Diagnostics Incorporated Hybrid phthalocyanine derivatives and their uses
US6811773B1 (en) 1993-12-22 2004-11-02 Human Genome Sciences, Inc. Human monocyte colony inhibitory factor (M-CIF) polypeptides
US6113855A (en) 1996-11-15 2000-09-05 Biosite Diagnostics, Inc. Devices comprising multiple capillarity inducing surfaces
US5947124A (en) 1997-03-11 1999-09-07 Biosite Diagnostics Incorporated Diagnostic for determining the time of a heart attack
US6057098A (en) 1997-04-04 2000-05-02 Biosite Diagnostics, Inc. Polyvalent display libraries
IL163547A0 (en) * 2002-02-12 2005-12-18 Quark Biotech Inc Use of the axl receptor for diagnosis and treatment of renal disease
US20120064089A1 (en) * 2002-11-15 2012-03-15 Morehouse School Of Medicine Anti-cxcl16 and anti-cxcr6 antibodies for the prevention and treatment of cancer and cancer cell migration
AU2006272913B2 (en) 2005-07-21 2012-01-19 The Johns Hopkins University Methods of detecting and treating acute kidney injury
CA2663749A1 (en) 2005-09-21 2007-03-29 Dask Technologies, Llc Methods and compositions for organ and tissue functionality
US20110059537A1 (en) 2007-09-20 2011-03-10 Caritas St. Elizabeth's Medical Center Of Boston, Inc. Method for estimating risk of acute kidney injury
WO2009114110A1 (en) 2008-03-08 2009-09-17 Immungene, Inc. Engineered fusion molecules immunotherapy in cancer and inflammatory diseases
WO2010048347A2 (en) * 2008-10-21 2010-04-29 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US20110065599A1 (en) * 2009-08-07 2011-03-17 Rules-Based Medicine, Inc. Methods and Devices for Detecting Kidney Damage
NZ630277A (en) * 2009-09-21 2015-02-27 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2496942B1 (en) 2009-11-07 2017-03-22 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CA2779905A1 (en) 2009-11-07 2011-05-12 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US20120156701A1 (en) * 2009-12-20 2012-06-21 Joseph Anderberg Methods and compositions for diagnosis and prognosis of renal injury and renal failure
JP5763098B2 (ja) 2009-12-20 2015-08-12 アスチュート メディカル,インコーポレイテッド 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物
PT2666872T (pt) * 2010-02-05 2016-07-08 Astute Medical Inc Processos e composições para o diagnóstico e o prognóstico de lesões renais e de insuficiência renal
NZ605698A (en) * 2010-06-23 2015-03-27 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2899545B1 (en) * 2010-06-23 2018-08-22 Astute Medical, Inc. Methods for diagnosis and prognosis of renal injury and renal failure
IN2012MN02812A (https=) * 2010-06-23 2015-05-22 Astute Medical Inc
UY33492A (es) * 2010-07-09 2012-01-31 Abbott Lab Inmunoglobulinas con dominio variable dual y usos de las mismas
EP2694974B1 (en) 2011-04-04 2015-10-21 Universiteit Gent Biomarkers for acute kidney injury
CN103874923B (zh) * 2011-08-26 2016-09-14 阿斯图特医药公司 用于肾损伤和肾衰竭的诊断及预后的方法和组合物
ES2734494T3 (es) * 2011-12-08 2019-12-10 Astute Medical Inc Métodos y usos para el diagnóstico de una lesión renal y de una insuficiencia renal
WO2013096740A1 (en) * 2011-12-21 2013-06-27 Alere San Diego Inc. Methods and compositions for assigning likelihood of chronic kidney disease progression
EP2962109A4 (en) 2013-02-26 2016-12-07 Astute Medical Inc METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
CN107003301B (zh) 2014-10-20 2019-11-01 阿斯图特医药公司 用于诊断和预后肾损伤和肾衰竭的方法和组合物

Similar Documents

Publication Publication Date Title
JP2022046669A5 (https=)
NO20076656L (no) Forbedrede immunoassay metoder
CN111033237B (zh) 使用剂量响应曲线的递减信号部分来测量包括高浓度分析物在内的分析物的夹心式测定
JP2022091846A5 (https=)
JP5553615B2 (ja) プロゾーン現象の低減を示すイムノアッセイ
KR102425258B1 (ko) 검체 수집 및 분석 일체형 디바이스, 및 이를 이용한 질병 진단용 정보 제공 방법
DK1739430T3 (da) Fremgangsmåde til assay af cardiovaskulære sygdomme
JP6440719B2 (ja) 腎疾患のバイオマーカー
JP2020504157A5 (https=)
JP2022532947A5 (https=)
JP1750163S (ja) 試料収集器
WO2015192854A2 (en) Methods and tools for predicting steatohepatitis
JP2024061719A (ja) ウイルス感染と細菌感染を区別するためのマルチプレックスラテラルフローアッセイ
Hassan et al. Pleural fluid analysis: standstill or a work in progress?
JP2021510815A5 (https=)
CN104360083A (zh) 一种定量检测类风湿因子、抗链球菌溶血素o、c反应蛋白的检测试剂盒
CN106153923B (zh) 预测谷丙转氨酶小于二倍正常上限的慢性乙型病毒性肝炎患者肝脏炎症程度的系统
WO2023122562A3 (en) Reflex test for immunoassay for anti-sars-cov-2 antibodies
Khashayar et al. PoCOsteo: generic novel platform for bone turnover marker measurement & monitoring
RU2008130888A (ru) Мас-2вр как маркер для диагностики рака желудка
CN202101997U (zh) 快速诊断急性心肌梗死的检测装置
JP2008180543A (ja) 分離デバイス、血液成分測定デバイス、血液成分測定システム、分離機能物質、血液成分測定方法、および分離方法。
RU2008139607A (ru) Новый анализ для обнаружения антитела, связанного с мембранным рецептором клетки
WO2007148720A1 (ja) ネフローゼ症候群の疾患関連たんぱく質およびその使用
Abe et al. Quantitative analysis of plasma interleiukin-6 by immunoassay on microchip